-DOCSTART-	O

Multiple	O
erythematous	O
papules	O
accompanied	O
by	O
severe	O
pruritus	B-NEG
were	O
observed	O
in	O
humans	O
bitten	O
by	O
the	O
mites	O
(	O
Acari	O
)	O
Pyemotes	O
tritici	O
(	O
Newport	O
)	O
(	O
Pyemotidae	O
)	O
,	O
Dermanyssus	O
gallinae	O
(	O
De	O
Geer	O
)	O
(	O
Dermanyssidae	O
)	O
,	O
Ornithonyssus	O
bacoti	O
Hirst	O
(	O
Macronyssidae	O
)	O
and	O
Androlaelaps	O
casalis	O
(	O
Berlese	O
)	O
(	O
Laelapidae	O
)	O
.	O

-DOCSTART-	O

Four	O
geographically	O
distinct	O
colonies	O
of	O
the	O
human	O
head	B-NEG
louse	I-NEG
,	O
Pediculus	O
humanus	O
capitis	O
De	O
Geer	O
(	O
Anoplura	O
Pediculidae	O
)	O
were	O
reared	O
on	O
a	O
live	O
host	O
and	O
exhibited	O
significantly	O
different	O
life	O
history	O
patterns	O
.	O

-DOCSTART-	O

We	O
investigated	O
the	O
effect	O
of	O
Maimendongtang	O
on	O
airway	O
clearance	O
and	O
secretion	B-NEG
in	O
anaesthetized	O
quails	O
.	O

-DOCSTART-	O

L	O
Yaojiu	O
was	O
investigated	O
for	O
its	O
effects	O
of	O
invigorating	O
blood	B-NEG
circulation	I-NEG
and	O
eliminating	O
blood	B-NEG
stasis	I-NEG
using	O
old	O
rats	O
(	O
aged	O
over	O
ten	O
months	O
)	O
as	O
the	O
model	O
of	O
blood	O
stasis	O
.	O

-DOCSTART-	O

The	O
effects	O
of	O
Guilingji	O
,	O
an	O
antiaging	O
prescription	O
comprised	O
of	O
traditional	O
Chinese	O
medicinal	O
herbs	O
and	O
animal	O
components	O
,	O
on	O
the	O
brain	B-NEG
level	O
of	O
thiobarbituric	O
acid	O
reactive	O
substances	O
(	O
TBARS	O
)	O
and	O
superoxide	O
dismutase	O
(	O
SOD	O
)	O
activity	O
in	O
the	O
brain	O
of	O
rats	O
with	O
FeCl3-induced	O
epilepsy	O
were	O
examined	O
with	O
fluorophotometry	O
and	O
electron	O
spin	O
resonance	O
(	O
ESR	O
)	O
spectrometry	O
,	O
respectively	O
.	O

-DOCSTART-	O

Isolation	O
and	O
elucidation	O
of	O
chemical	O
constituents	O
with	O
antiviral	O
action	O
from	O
yinqiaosan	O
on	O
influenza	B-NEG
virus	I-NEG
.	O

-DOCSTART-	O

Shosaikoto	O
and	O
Daisaikoto	O
elevated	O
the	O
mitogenic	O
activity	O
of	O
LPS	B-NEG
and	O
reduced	O
those	O
of	O
Con	B-NEG
A	I-NEG
.	O

-DOCSTART-	O

Study	O
on	O
the	O
immunoregulatory	O
effect	O
of	O
Baoyuantang	O
(	O
symbol	O
see	O
text	O
)	O
in	O
patients	O
with	O
chronic	B-NEG
hepatitis	I-NEG
B	I-NEG
.	O

-DOCSTART-	O

When	O
120	O
mg	O
kg	O
day	O
of	O
Shosaikoto	O
extract	O
was	O
placed	O
in	O
the	O
diet	O
after	O
72	O
weeks	O
of	O
age	O
to	O
110	O
weeks	O
,	O
it	O
improved	O
age-induced	O
PAR	B-NEG
failure	I-NEG
in	O
both	O
the	O
two-compartment	O
avoidance	O
box	O
test	O
and	O
the	O
step-down	O
test	O
.	O

-DOCSTART-	O

Moreover	O
,	O
takushya	O
was	O
responsible	O
for	O
most	O
of	O
the	O
effect	O
of	O
choreito	O
consumption	O
on	O
reduction	O
of	O
urine	B-NEG
pH	I-NEG
,	O
and	O
approximately	O
half	O
its	O
ability	O
to	O
reduce	O
struvite	B-NEG
crystal	I-NEG
formation	I-NEG
in	O
cat	O
urine	O
.	O

-DOCSTART-	O

CONCLUSION	O
Didang	O
Tang	O
and	O
Guizhifuling	O
pills	O
can	O
reduce	O
the	O
expressions	O
of	O
hTERT	B-NEG
,	O
p53	B-NEG
,	I-NEG
	I-NEG
c-	B-NEG
erbB-2	I-NEG
and	O
Bcl-2	B-NEG
,	O
while	O
Danshenyin	O
can	O
only	O
reduce	O
the	O
expression	O
of	O
hTERT	B-NEG
without	O
similar	O
effects	O
on	O
the	O
other	O
3	O
oncogenes	O
.	O

-DOCSTART-	O

Effects	O
of	O
choreito	O
consumption	O
on	O
urine	B-NEG
variables	O
of	O
healthy	O
cats	O
fed	O
a	O
magnesium-supplemented	O
commercial	O
diet	O
.	O

-DOCSTART-	O

Through	O
the	O
morphological	O
and	O
biochemical	O
analyses	O
,	O
it	O
was	O
shown	O
that	O
HiB5	O
cells	O
treated	O
with	O
H2O2	O
exhibit	O
classical	O
apoptotic	B-NEG
features	I-NEG
,	O
while	O
the	O
occurrence	O
of	O
such	O
changes	O
is	O
reduced	O
in	O
cells	O
pre-treated	O
with	O
Wuyaoshunqisan	O
prior	O
to	O
H2O2	O
exposure	O
.	O

-DOCSTART-	O

Although	O
normal	O
sperm	O
with	O
ASA	O
was	O
used	O
in	O
this	O
report	O
,	O
since	O
the	O
sperm	O
of	O
infertile	O
patients	O
are	O
said	O
to	O
be	O
more	O
fragile	O
,	O
this	O
results	O
imply	O
that	O
direct	O
protective	O
effect	O
is	O
one	O
of	O
the	O
mechanism	O
of	O
Hochuekkito	O
for	O
male	B-NEG
infertility	I-NEG
.	O

-DOCSTART-	O

The	O
oral	O
administration	O
of	O
7	O
.	O

5	O
g	O
day	O
of	O
Goshajinkigan	O
for	O
3	O
months	O
(	O
treatment	O
period	O
)	O
relieved	O
subjective	O
symptoms	O
of	O
numbness	B-NEG
in	O
9	O
of	O
13	O
patients	O
.	O

-DOCSTART-	O

To	O
study	O
whether	O
Saireito-stimulated	O
secretion	O
and	O
synthesis	O
of	O
ACTH	B-NEG
are	O
mediated	O
by	O
hypothalamic	O
corticotropin-releasing	O
factor	O
(	O
CRF	B-NEG
)	O
,	O
we	O
examined	O
the	O
effect	O
of	O
passive	O
immunization	O
of	O
endogenous	O
CRF	O
by	O
i	O
.	O

v	O
.	O
administration	O
of	O
CRF	O
antiserum	O
on	O
Saireito-increased	O
plasma	O
ACTH	B-NEG
levels	O
and	O
proopiomelanocortin	B-NEG
gene	I-NEG
expression	I-NEG
in	O
the	O
rat	O
anterior	O
pituitary	O
,	O
under	O
pentobarbital	O
anesthesia	O
.	O

-DOCSTART-	O

These	O
results	O
suggest	O
that	O
Hachimijiogan	O
acts	O
on	O
the	O
afferent	B-NEG
pathway	I-NEG
from	O
the	O
urinary	O
bladder	B-NEG
to	O
the	O
locus	O
coeruleus	O
,	O
thereby	O
inhibiting	O
the	O
micturition	B-NEG
reflex	O
,	O
while	O
it	O
has	O
no	O
effects	O
on	O
the	O
efferent	B-NEG
pathway	I-NEG
from	O
the	O
locus	O
coeruleus	O
to	O
the	O
urinary	O
bladder	O
.	O

-DOCSTART-	O

We	O
treated	O
53	O
patients	O
for	O
male	B-NEG
infertility	I-NEG
with	O
TSUMURA	O
-	O
Hachimijiogan	O
given	O
as	O
a	O
daily	O
dose	O
of	O
7	O
.	O

5	O
g	O
for	O
144	O
days	O
on	O
the	O
average	O
.	O

-DOCSTART-	O

AIM	O
To	O
investigate	O
the	O
role	O
of	O
tumor	B-NEG
necrosis	I-NEG
factor	I-NEG
(	O
TNF	O
)	O
in	O
lung	B-NEG
injury	I-NEG
during	O
acute	B-NEG
necrotizing	I-NEG
pancreatitis	I-NEG
(	O
ANP	O
)	O
,	O
and	O
the	O
therapeutic	O
effect	O
of	O
Tong	O
Xia	O
purgative	O
method	O
in	O
minimizing	O
the	O
severity	O
of	O
lung	O
injury	O
.	O

METHODS	O
Fourteen	O
canines	O
were	O
randomly	O
divided	O
into	O
3	O
groups	O
the	O
Tong	O
Xia	O
treatment	O
group	O
(	O
n	O
5	O
)	O
using	O
Dachengqitang	O
saline	O
control	O
group	O
(	O
n	O
5	O
)	O
,	O
and	O
the	O
sham	O
operation	O
group	O
(	O
n	O
4	O
)	O
.	O

-DOCSTART-	O

In	O
accordance	O
with	O
the	O
International	O
Code	O
of	O
Zoological	O
Nomenclature	O
,	O
the	O
names	O
of	O
Pediculus	O
humanus	O
L	O
.	O
,	O
1758	O
,	O
and	O
Pediculus	B-NEG
corporis	I-NEG
De	O
Geer	O
,	O
1778	O
,	O
are	O
proposed	O
for	O
head	B-NEG
and	I-NEG
body	I-NEG
lice	I-NEG
,	O
respectively	O
.	O

-DOCSTART-	O

We	O
have	O
generated	O
L-selectin-deficient	O
mice	O
by	O
targeted	O
disruption	O
,	O
and	O
have	O
confirmed	O
a	O
previously	O
reported	O
phenotype	O
which	O
includes	O
strikingly	O
impaired	O
contact	B-NEG
hypersensitivity	I-NEG
(	O
CHS	B-NEG
)	O
responses	O
to	O
reactive	O
haptens	O
(	O
Tedder	O
,	O
T	O
.	O
F	O
.	O
,	O
D	O
.	O
A	O
.	O
Steeber	O
,	O
and	O
P	O
.	O
Pizcueta	O
.	O
1995	O
.	O
J	O
.	O
Exp	O
.	O
Med	O
.	O
181	O
2259-2264	O
Xu	O
,	O
J	O
.	O
C	O
.	O
,	O
I	O
.	O
S	O
.	O
Grewal	O
,	O
G	O
.	O
P	O
.	O
Geba	O
,	O
and	O
R	O
.	O
A	O
.	O
Flavell	O
.	O
1996	O
.	O
183	O
589-598	O
.	O
)	O
.	O

-DOCSTART-	O

Shosaikoto	O
has	O
been	O
identified	O
as	O
the	O
cause	O
of	O
interstitial	B-NEG
pneumonia	I-NEG
or	O
eosinophilic	B-NEG
pneumonia	I-NEG
,	O
but	O
pulmonary	B-NEG
edema	I-NEG
associated	O
with	O
Shosaikoto	O
has	O
not	O
been	O
previously	O
described	O
.	O

-DOCSTART-	O

Jagamchotang	O
has	O
been	O
used	O
for	O
treatment	O
of	O
ischemic	B-NEG
myocardial	I-NEG
diseases	I-NEG
in	O
Chinese	O
traditional	O
medicine	O
.	O

-DOCSTART-	O

This	O
study	O
was	O
designed	O
to	O
evaluate	O
whether	O
the	O
water	O
extract	O
of	O
Samultang	O
may	O
modulate	O
the	O
production	B-NEG
of	I-NEG
nitric	I-NEG
oxide	I-NEG
(	O
NO	O
)	O
in	O
LPS	O
and	O
PMA	O
treated-C6	O
glial	O
cells	O
to	O
protect	O
the	O
cells	O
from	O
NO	B-NEG
-induced	O
cytotoxicity	B-NEG
.	O

-DOCSTART-	O

Head	B-NEG
lice	I-NEG
are	O
caused	O
by	O
the	O
host-specific	O
,	O
ectoparasitic	O
insect	O
Pediculus	O
humanus	O
capitis	O
De	O
Geer	O
and	O
remain	O
a	O
common	O
human	O
infestation	O
.	O

-DOCSTART-	O

On	O
the	O
other	O
hand	O
,	O
Daiobotanpito	O
and	O
Tokakujokito	O
were	O
not	O
blocked	O
by	O
treatment	O
with	O
those	O
four	O
inhibitors	B-NEG
.	O

-DOCSTART-	O

An	O
illustration	O
of	O
the	O
feasibility	O
of	O
extending	O
the	O
dose	O
reconstruction	O
is	O
provided	O
by	O
a	O
sample	O
calculation	O
to	O
estimate	O
radiation	B-NEG
exposures	I-NEG
to	O
the	O
thyroid	B-NEG
from	O
eating	O
radio-iodine-contaminated	O
rabbit	O
thyroids	O
after	O
the	O
Sedan	O
test	O
.	O

-DOCSTART-	O

However	O
,	O
Samultang	O
significantly	O
reduced	O
both	O
cell	B-NEG
death	I-NEG
and	O
NO	B-NEG
production	I-NEG
by	O
LPS	B-NEG
	I-NEG
PMA	B-NEG
in	O
a	O
dose-dependent	O
manner	O
.	O

-DOCSTART-	O

Effects	O
of	O
goshajinkigan	O
on	O
corneal	B-NEG
sensitivity	I-NEG
,	O
superficial	B-NEG
punctate	I-NEG
keratopathy	I-NEG
and	O
tear	B-NEG
secretion	O
in	O
patients	O
with	O
insulin-dependent	B-NEG
diabetes	I-NEG
mellitus	I-NEG
.	O

-DOCSTART-	O

Results	O
showed	O
that	O
Scutellaria	O
barbata	O
,	O
Hedyotis	O
diffusa	O
wildi	O
,	O
Xihuangwan	O
,	O
green	O
tea	O
and	O
tea	O
polyphenol	O
all	O
had	O
anti-mutagenic	B-NEG
effects	I-NEG
,	O
to	O
some	O
extent	O
.	O

-DOCSTART-	O

Identification	O
of	O
two	O
allatostatins	O
from	O
the	O
cricket	O
,	O
Gryllus	O
bimaculatus	O
de	O
Geer	O
(	O
Ensifera	O
,	O
Gryllidae	O
)	O
additional	O
members	O
of	O
a	O
family	O
of	O
neuropeptides	O
inhibiting	O
juvenile	O
hormone	B-NEG
biosynthesis	I-NEG
.	O

-DOCSTART-	O

Effect	O
of	O
zuoguiwan	O
on	O
early	B-NEG
embryonic	I-NEG
development	I-NEG
of	O
mice	O
.	O

-DOCSTART-	O

The	O
effect	O
of	O
a	O
dietary	O
supplement	O
,	O
choreito	O
,	O
on	O
in	O
vitro	O
struvite	B-NEG
crystal	I-NEG
growth	O
in	O
feline	O
urine	O
was	O
evaluated	O
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
investigate	O
the	O
therapeutic	O
efficacy	O
of	O
traditional	O
Chinese	O
medicine	O
Reduqing	O
(	O
RDQ	O
)	O
against	O
human	O
cytomegalovirus	B-NEG
(	O
HCMV	O
)	O
in	O
clinical	O
and	O
its	O
antiviral	B-NEG
activity	I-NEG
in	O
vitro	O
.	O

-DOCSTART-	O

In	O
the	O
present	O
study	O
,	O
we	O
examined	O
the	O
effect	O
of	O
food	O
containing	O
saireito	O
(	O
1	O
.	O
5	O
)	O
on	O
the	O
recovery	O
of	O
the	O
hypothalamic-pituitary-adrenal	B-NEG
axis	I-NEG
after	O
treating	O
male	O
rats	O
with	O
prednisolone	O
(	O
PSL	O
,	O
200	O
microM	O
)	O
in	O
drinking	O
water	O
for	O
14	O
days	O
.	O

-DOCSTART-	O

Pingandan	O
was	O
a	O
secret	O
prescription	O
for	O
treatment	O
of	O
stomach	B-NEG
upset	I-NEG
,	O
nausea	B-NEG
and	O
vomiting	B-NEG
for	O
emperors	O
in	O
the	O
Qing	O
Dynasty	O
of	O
China	O
.	O

-DOCSTART-	O

METHODS	O
Wistar	O
rats	O
were	O
divided	O
into	O
wet-heat	B-NEG
syndrome	I-NEG
group	O
,	O
qingxiangsan	O
group	O
and	O
normal	O
control	O
group	O
.	O

-DOCSTART-	O

Effects	O
of	O
herbal	O
components	O
of	O
tokishakuyakusan	O
on	O
progesterone	B-NEG
secretion	O
by	O
corpus	O
luteum	O
in	O
vitro	O
.	O

-DOCSTART-	O

The	O
results	O
suggest	O
that	O
Shiunko	O
is	O
an	O
effective	O
ointment	O
for	O
cutaneous	B-NEG
injuries	I-NEG
.	O

-DOCSTART-	O

Furthermore	O
,	O
the	O
effects	O
of	O
tokishakuyakusan	O
on	O
prolactin	B-NEG
,	O
gonadotropins	B-NEG
,	O
steroids	B-NEG
,	O
angiotensin	B-NEG
II	I-NEG
,	O
ANP	B-NEG
and	O
renin	B-NEG
levels	I-NEG
in	O
the	O
blood	O
of	O
women	O
with	O
normal	O
menstrual	O
cycles	O
were	O
studied	O
,	O
as	O
were	O
the	O
medicine	O
s	O
effects	O
on	O
estrogens	B-NEG
,	O
pregnenediol	O
and	O
LH	B-NEG
in	O
the	O
urine	O
of	O
the	O
same	O
women	O
.	O

-DOCSTART-	O

Effects	O
of	O
Hachimijiogan	O
on	O
hypothalamo-pituitary-testicular	B-NEG
system	I-NEG
.	O

-DOCSTART-	O

The	O
results	O
suggest	O
that	O
Shiunko	O
may	O
have	O
antibacterial	O
effects	O
on	O
staphylococci	B-NEG
,	O
and	O
may	O
be	O
an	O
effective	O
treatment	O
for	O
atopic	B-NEG
dermatitis	I-NEG
and	O
other	O
skin	B-NEG
infections	I-NEG
caused	O
mainly	O
by	O
Staphylococcus	B-NEG
species	O
.	O

-DOCSTART-	O

To	O
clarify	O
the	O
mechanism	O
of	O
combined	O
effects	O
of	O
prednisolone	O
and	O
Shosaikoto	O
,	O
the	O
effects	O
of	O
Shosaikoto	O
on	O
the	O
blood	O
prednisolone	B-NEG
level	I-NEG
and	O
on	O
the	O
secretion	O
of	O
endogenous	B-NEG
glucocorticoid	I-NEG
(	O
corticosterone	O
)	O
were	O
investigated	O
by	O
high	O
performance	O
liquid	O
chromatography	O
.	O

-DOCSTART-	O

Saibokuto	O
inhibited	O
in	O
vitro	O
PAF	B-NEG
production	O
in	O
a	O
dose-dependent	O
manner	O
.	O

-DOCSTART-	O

The	O
above	O
findings	O
suggested	O
Shosaikoto-induced	O
non-cardiogenic	B-NEG
pulmonary	I-NEG
edema	I-NEG
,	O
a	O
rarely	O
seen	O
disorder	O
.	O

-DOCSTART-	O

Therefore	O
,	O
Choreito	O
was	O
thought	O
to	O
be	O
an	O
effective	O
drug	O
for	O
the	O
patients	O
with	O
lower	B-NEG
urinary	I-NEG
tract	I-NEG
symptoms	I-NEG
.	O

-DOCSTART-	O

424	O
pregnant	O
women	O
(	O
MAP-2	O
greater	O
than	O
or	O
equal	O
to	O
12kPa	O
)	O
were	O
divided	O
into	O
4	O
groups	O
and	O
given	O
preventive	O
treatment	O
as	O
follows	O
(	O
1	O
)	O
The	O
control	O
group	O
,	O
122	O
women	O
,	O
no	O
drugs	O
were	O
given	O
(	O
2	O
)	O
the	O
Theragan	O
group	O
,	O
102	O
women	O
(	O
3	O
)	O
the	O
TCM	O
(	O
A	O
)	O
group	O
,	O
100	O
women	O
,	O
those	O
with	O
Liver-Kidney	B-NEG
deficiency	I-NEG
of	O
Yin	O
or	O
no	O
apparent	O
signs	O
were	O
given	O
Qiju	O
Dihuang	O
Wan	O
,	O
and	O
those	O
with	O
Spleen-Kidney	B-NEG
deficiency	I-NEG
of	O
Yang	O
were	O
given	O
Shenqiwan	O
(	O
4	O
)	O
the	O
TCM	O
(	O
B	O
)	O
group	O
,	O
100	O
women	O
,	O
were	O
given	O
Salvia	O
miltiorrhiza	O
plus	O
(	O
A	O
)	O
group	O
s	O
drugs	O
.	O

-DOCSTART-	O

Adjuvant	O
therapy	O
with	O
Shosaikoto	O
and	O
Hocheukito	O
suppressed	O
INH	O
induced	O
hepato-dermatological	B-NEG
toxicosis	I-NEG
moderately	O
and	O
suppressed	O
SM	O
induced	O
high	B-NEG
fever	I-NEG
completely	O
.	O

-DOCSTART-	O

Effect	O
of	O
Qingyitang	O
on	O
activity	O
of	O
intracellular	O
Ca2	O
-Mg2	O
-ATPase	O
in	O
rats	O
with	O
acute	B-NEG
pancreatitis	I-NEG
.	O

-DOCSTART-	O

Endothelin-1	B-NEG
levels	O
are	O
not	O
influenced	O
by	O
tokishakuyakusan	O
and	O
keishibukuryogan	O
treatment	O
in	O
women	O
.	O

-DOCSTART-	O

Eleven	O
patients	O
with	O
lumbago	B-NEG
due	O
to	O
renal	O
ptosis	O
,	O
and	O
23	O
patients	O
with	O
stress	B-NEG
incontinence	I-NEG
were	O
treated	O
with	O
Tsumura	O
Hotyuekkito	O
(	O
Buzhongyiqitang	O
)	O
,	O
an	O
old	O
Chinese	O
prescription	O
,	O
7	O
.	O

5	O
g	O
,	O
three	O
times	O
a	O
day	O
.	O

-DOCSTART-	O

Sannoshashinto	O
,	O
however	O
,	O
appeared	O
to	O
accelerate	O
the	O
disappearance	O
of	O
cholesterol	B-NEG
from	O
blood	O
,	O
while	O
Daisaikoto	O
inhibited	O
the	O
cholesterol	B-NEG
absorption	O
from	O
the	O
intestine	O
.	O

-DOCSTART-	O

These	O
results	O
suggest	O
that	O
Saireito	O
does	O
not	O
stimulate	O
CRF	B-NEG
gene	I-NEG
expression	I-NEG
,	O
although	O
it	O
does	O
stimulate	O
CRF	B-NEG
release	O
,	O
which	O
in	O
turn	O
stimulates	O
POMC	B-NEG
gene	I-NEG
expression	I-NEG
in	O
the	O
anterior	O
pituitary	O
and	O
ACTH	B-NEG
release	O
.	O

-DOCSTART-	O

Effect	O
of	O
baoyuantang	O
on	O
erythroid	O
progenitor	O
and	O
clinical	O
observation	O
in	O
chronic	B-NEG
renal	I-NEG
failure	I-NEG
patients	O
.	O

-DOCSTART-	O

Conclusively	O
,	O
Shosaikoto	O
prevents	O
the	O
modification	B-NEG
of	I-NEG
macrophage	I-NEG
function	O
induced	O
by	O
atherogenic	O
factors	O
,	O
which	O
is	O
probably	O
linked	O
to	O
its	O
displayed	O
anti-atherosclerotic	B-NEG
action	I-NEG
.	O

-DOCSTART-	O

Immunoregulation	O
of	O
Youguiyin	O
,	O
Sijunzitang	O
,	O
Taohong	O
Siwutang	O
in	O
treating	O
patients	O
with	O
deficiency	O
of	O
kidney	B-NEG
,	O
spleen	B-NEG
and	O
blood	B-NEG
stasis	I-NEG
syndrome	I-NEG
.	O

-DOCSTART-	O

Saibokuto	O
also	O
suppressed	O
the	O
induced	O
IL2	B-NEG
responsiveness	I-NEG
of	O
lymphocytes	O
from	O
the	O
same	O
patients	O
on	O
stimulation	O
wit	O
PPD	O
,	O
but	O
not	O
with	O
Con	O
A	O
.	O

-DOCSTART-	O

These	O
results	O
suggest	O
that	O
Hachimijiogan	O
possesses	O
a	O
wide-ranging	O
pharmacological	O
profile	O
in	O
anti-amnesic	B-NEG
actions	I-NEG
and	O
that	O
its	O
anti-amnesic	O
activities	O
may	O
be	O
related	O
to	O
the	O
cholinergic	O
neuronal	O
system	O
.	O

-DOCSTART-	O

Permethrin-resistant	O
colonies	O
of	O
Pediculus	B-NEG
capitis	I-NEG
(	O
De	O
Geer	O
)	O
from	O
Buenos	O
Aires	O
were	O
used	O
to	O
establish	O
a	O
resistance	O
profile	O
and	O
to	O
examine	O
resistance	O
mechanisms	O
.	O

-DOCSTART-	O

Hwansodan	O
protects	O
PC12	B-NEG
cells	I-NEG
against	O
serum-deprivation-induced	O
apoptosis	B-NEG
via	O
a	O
mechanism	O
involving	O
Ras	B-NEG
and	O
mitogen-activated	B-NEG
protein	I-NEG
(	O
MAP	B-NEG
)	O
kinase	O
pathway	O
.	O

-DOCSTART-	O

Effect	O
of	O
reduqing	O
on	O
HL-60	B-NEG
cells	I-NEG
in	O
secreting	O
tumor	B-NEG
necrosis	I-NEG
factor	I-NEG
alpha	I-NEG
production	I-NEG
and	O
on	O
TNF	B-NEG
alpha	I-NEG
converting	I-NEG
enzyme	I-NEG
mRNA	I-NEG
expression	I-NEG
.	O

-DOCSTART-	O

Furthermore	O
,	O
we	O
found	O
that	O
Maimendongtang	O
significantly	O
restored	O
HNE-induced	O
increases	O
in	O
DNA	B-NEG
,	O
fucose	B-NEG
and	O
protein	B-NEG
contents	O
of	O
airway	B-NEG
surface	I-NEG
fluid	I-NEG
(	O
ASF	B-NEG
)	O
,	O
whereas	O
only	O
Maimendongtang	O
itself	O
significantly	O
decreased	O
the	O
protein	B-NEG
content	O
.	O

-DOCSTART-	O

In	O
the	O
present	O
study	O
we	O
conducted	O
rat	O
liver	O
perfusion	O
using	O
the	O
HMG	O
Co	O
A	O
reductase	O
inhibitor	O
(	O
CS-514	O
)	O
and	O
Kampo	O
medicine	O
(	O
Daisaikoto	O
)	O
to	O
elucidate	O
the	O
mechanism	O
of	O
the	O
effect	O
of	O
dietary	O
cholesterol	B-NEG
on	O
hepatic	O
lipoprotein	O
and	O
apolipoprotein	O
synthesis	O
.	O

-DOCSTART-	O

Effects	O
of	O
oral	O
administration	O
of	O
Juzentaihoto	O
,	O
a	O
herb	O
drug	O
,	O
on	O
the	O
toxic	O
side	O
effects	O
of	O
cis-diammine	O
dichloroplatinum	O
(	O
CDDP	O
)	O
and	O
combination	O
effects	O
with	O
CDDP	O
on	O
murine	O
bladder	B-NEG
tumor	I-NEG
(	O
MBT	O
2	O
)	O
were	O
studied	O
using	O
C3H	O
He	O
male	O
mice	O
.	O

-DOCSTART-	O

In	O
the	O
presence	O
of	O
control	O
LDL	O
or	O
in	O
the	O
absence	O
of	O
LDL	O
,	O
incorporation	O
of	O
3H	O
oleic	O
acid	O
into	O
chlesteryl	O
oleate	O
was	O
significantly	O
reduced	O
in	O
Shosaikoto	O
treated	O
macrophages	B-NEG
.	O

-DOCSTART-	O

Hachimijiogan	O
treatment	O
is	O
effective	O
in	O
the	O
management	O
of	O
infertile	B-NEG
women	I-NEG
with	O
hyperprolactinemia	B-NEG
or	O
bromocriptine-resistant	O
hyperprolactinemia	O
.	O

-DOCSTART-	O

The	O
ancient	O
Chinese	O
remedy	O
Suanzaorentang	O
was	O
originally	O
described	O
in	O
Kin-Kue-Yao-Lueh	O
for	O
patients	O
with	O
weakness	B-NEG
,	O
irritability	B-NEG
and	O
insomnia	B-NEG
.	O

-DOCSTART-	O

SIGO	O
Study	O
Group	O
of	O
HIV	B-NEG
Infection	O
in	O
Pregnancy	O
.	O

-DOCSTART-	O

We	O
have	O
previously	O
demonstrated	O
that	O
transfected	O
hepatocellular	B-NEG
carcinoma	I-NEG
cells	O
(	O
Hepa1-6	O
)	O
with	O
one	O
copy	O
(	O
pAGO	O
)	O
and	O
two	O
copies	O
(	O
pYED	O
)	O
of	O
the	O
HSVtk	O
gene	O
,	O
using	O
liposomes	O
,	O
induced	O
cell	O
death	O
of	O
untransfected	O
cells	O
in	O
the	O
presence	O
of	O
ganciclovir	O
(	O
GCV	O
)	O
.	O

-DOCSTART-	O

pAGO-transformed	O
KY895	O
cells	O
exhibited	O
partially	O
restored	O
ability	O
to	O
incorporate	O
3H	O
dThd	O
into	O
DNA	O
and	O
an	O
HSv-1-specific	B-NEG
TK	I-NEG
activity	I-NEG
.	O

-DOCSTART-	O

The	O
clinical	O
evaluation	O
of	O
hochuekkito	O
for	O
symptoms	O
of	O
malignant	B-NEG
neoplasm	I-NEG
patients	O
.	O

-DOCSTART-	O

Thus	O
,	O
Saibokuto	O
enhances	O
ciliary	B-NEG
motility	I-NEG
probably	O
through	O
the	O
synthesis	O
of	O
cyclooxygenase	B-NEG
products	I-NEG
and	O
cyclic	B-NEG
AMP	I-NEG
.	O

-DOCSTART-	O

Hachimijiogan	O
changes	O
serum	O
hormonal	O
circumstance	O
and	O
improves	O
spermatogenesis	B-NEG
in	O
oligozoospermic	O
men	O
.	O

-DOCSTART-	O

Therapeutic	O
experiences	O
of	O
seishinrenshiin	O
in	O
patients	O
with	O
equivocal	O
complaints	O
of	O
the	O
lower	B-NEG
urinary	I-NEG
tract	I-NEG
.	O

-DOCSTART-	O

Furthermore	O
,	O
although	O
monocytes	O
from	O
hypercholesterolemic	O
rabbits	O
increased	O
in	O
adherence	O
to	O
endothelial	O
cells	O
even	O
without	O
lipopolysaccharide	O
(	O
LPS	O
)	O
activation	O
,	O
Shosaikoto	O
treatment	O
reduced	O
the	O
enhanced	O
adherence	B-NEG
observed	O
in	O
monocytes	O
from	O
hypercholesterolemic	O
rabbits	O
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
observe	O
the	O
effect	O
of	O
herbal	O
eye	O
drop	O
Reduqing	O
(	O
clearing	O
toxic	O
heat	O
)	O
on	O
herpes	B-NEG
simplex	I-NEG
virus	I-NEG
(	O
HSV	B-NEG
)	O
on	O
the	O
cytopathic	O
effect	O
in	O
cell	O
culture	O
in	O
vitro	O
.	O

-DOCSTART-	O

This	O
clinical	O
study	O
shows	O
that	O
CT-guided	O
stereotactic	O
biopsy	O
of	O
nonpolar	O
tumors	B-NEG
in	O
the	O
dominant	O
hemisphere	O
using	O
the	O
Brown-Roberts-Wells	O
system	O
and	O
the	O
Sedan-Nashold	O
biopsy	O
cannula	O
carries	O
a	O
9	O
risk	O
(	O
95	O
confidence	O
intervals	O
0-26	O
)	O
of	O
impairing	O
language	O
functions	O
if	O
the	O
patient	O
is	O
not	O
dysphasic	O
preoperatively	O
.	O

-DOCSTART-	O

The	O
combined	O
effects	O
of	O
Shosaikoto	O
,	O
one	O
of	O
the	O
Kampohozai	O
(	O
Chinese	O
traditional	O
medicine	O
)	O
,	O
and	O
prednisolone	O
were	O
examined	O
for	O
suppressive	O
actions	O
on	O
pituitary	B-NEG
adrenocortical	I-NEG
axis	I-NEG
function	O
and	O
immune	B-NEG
response	I-NEG
induced	O
by	O
prednisolone	O
using	O
rats	O
and	O
mice	O
.	O

-DOCSTART-	O

In	O
addition	O
,	O
treatment	O
with	O
shosaikoto	O
suppressed	O
intimal	B-NEG
hyperplasia	I-NEG
in	O
apoE-deficient	O
mice	O
fed	O
a	O
cholesterol-enriched	O
diet	O
for	O
nine	O
weeks	O
.	O

-DOCSTART-	O

The	O
effects	O
of	O
Shengmaisan	O
with	O
Astragalus	O
membranaceus	O
(	O
SMAM	O
)	O
on	O
anti-tumor	B-NEG
activity	I-NEG
of	O
LAK	O
cells	O
with	O
the	O
3H	O
release	O
assay	O
were	O
studied	O
.	O

-DOCSTART-	O

These	O
results	O
suggest	O
that	O
administration	O
of	O
TSUMURA-Goshajinkigan	O
is	O
effective	O
as	O
therapy	O
for	O
male	B-NEG
infertility	I-NEG
,	O
but	O
how	O
this	O
drug	O
may	O
be	O
involved	O
in	O
promoting	O
fertility	O
should	O
be	O
investigated	O
in	O
future	O
.	O

-DOCSTART-	O

In	O
the	O
case	O
of	O
combined	O
use	O
,	O
Shosaikoto	O
,	O
0	O
.	O

12	O
and	O
1	O
.	O

2	O
g	O
kg	O
p	O
.	O
o	O
.	O
,	O
inhibited	O
the	O
decrease	B-NEG
of	I-NEG
blood	I-NEG
corticosterone	I-NEG
level	I-NEG
induced	O
by	O
the	O
treatment	O
with	O
prednisolone	O
,	O
0	O
.	O

004	O
g	O
kg	O
p	O
.	O
o	O
.	O
,	O
and	O
Shosaikoto	O
,	O
1	O
.	O

2	O
g	O
kg	O
p	O
.	O
o	O
.	O
,	O
inhibited	O
the	O
decrease	O
of	O
blood	O
corticosterone	O
level	O
induced	O
by	O
the	O
treatment	O
with	O
prednisolone	O
,	O
0	O
.	O

016	O
g	O
kg	O
p	O
.	O
o	O
.	O

-DOCSTART-	O

Hachimijiogan	O
and	O
Tokishakuyakusan	O
enhance	O
deoxyribonucleic	B-NEG
acid	I-NEG
alpha-nucleotidyltransferase	I-NEG
activity	I-NEG
in	O
relationship	O
to	O
DNA	O
synthesis	O
by	O
ovarian	O
follicles	O
via	O
a	O
cyclic	O
AMP	O
system	O
.	O

-DOCSTART-	O

Suanzaorentang	O
in	O
cardiac	O
patients	O
with	O
anxiety	B-NEG
.	O

-DOCSTART-	O

RESULTS	O
Sijunzitang	O
could	O
reduce	O
the	O
level	O
of	O
CIC	B-NEG
(	O
P	O
0	O
.	O
01	O
)	O
,	O
raise	O
the	O
activity	B-NEG
of	I-NEG
NK	I-NEG
cell	I-NEG
and	O
LRT	B-NEG
(	O
P	O
0	O
.	O
01	O
)	O
of	O
the	O
patients	O
with	O
deficiency	B-NEG
of	I-NEG
Spleen	I-NEG
syndrome	I-NEG
the	O
same	O
did	O
the	O
Youguiyin	O
to	O
that	O
of	O
patients	O
with	O
deficiency	B-NEG
of	I-NEG
Kidney	I-NEG
syndrome	I-NEG
.	O

-DOCSTART-	O

A	O
deletion	B-NEG
mutant	I-NEG
of	O
pAGO	O
,	O
designated	O
pMH110	O
,	O
has	O
been	O
isolated	O
which	O
removes	O
the	O
normal	O
HSV-1	B-NEG
TK	I-NEG
gene	I-NEG
promoter	I-NEG
but	O
places	O
the	O
promoter	O
of	O
the	O
pBR322	B-NEG
tetracycline-resistance	I-NEG
(	I-NEG
tetr	I-NEG
)	I-NEG
gene	I-NEG
only	O
about	O
400	O
bp	O
from	O
the	O
translational	O
start	O
codon	O
of	O
the	O
HSV-1	B-NEG
TK	I-NEG
polypeptide	I-NEG
.	O

-DOCSTART-	O

METHODS	O
Fourty	O
cases	O
with	O
close	O
fractures	B-NEG
of	O
tibia	O
and	O
fibula	O
were	O
included	O
and	O
divided	O
into	O
two	O
groups	O
randomly	O
the	O
experimental	O
group	O
was	O
administrated	O
with	O
phenytoin	O
and	O
Chinese	O
traditional	O
drug-Jiegudan	O
orally	O
,	O
while	O
the	O
control	O
group	O
was	O
given	O
Jiegudan	O
only	O
.	O

-DOCSTART-	O

There	O
was	O
also	O
a	O
significant	O
association	O
between	O
dental	B-NEG
anxiety	I-NEG
and	O
general	O
fearfulness	B-NEG
measured	O
by	O
the	O
Fear	O
Survey	O
Schedule	O
II	O
(	O
Geer	O
,	O
1965	O
)	O
(	O
r	O
0	O
.	O
31	O
p	O
less	O
than	O
0	O
.	O
001	O
)	O
.	O

-DOCSTART-	O

These	O
results	O
indicate	O
that	O
the	O
administration	O
of	O
saireito	O
reduces	O
the	O
negative	B-NEG
feedback	I-NEG
effect	I-NEG
of	I-NEG
PSL	I-NEG
on	O
the	O
hypothalamus	O
and	O
pituitary	O
and	O
accelerates	O
the	O
recovery	O
of	O
the	O
hypothalamic	B-NEG
CRH	I-NEG
and	O
pituitary	O
ACTH	B-NEG
level	O
after	O
glucocorticoid	O
treatment	O
.	O

-DOCSTART-	O

OBJECTIVE	O
To	O
study	O
the	O
anti-aging	O
mechanism	O
of	O
Zuoguiyin	O
(	O
a	O
prescription	O
for	O
tonifying	O
Kindney	O
Yin	O
)	O
and	O
Yishenbao	O
(	O
a	O
prescription	O
for	O
tonifying	O
Kidney	B-NEG
Yang	O
)	O
in	O
presenile	O
mice	O
.	O

-DOCSTART-	O

Effects	O
of	O
hachimijiogan	O
,	O
tokishakuyakusan	O
,	O
keishibukuryogan	O
,	O
ninjinto	O
and	O
unkeito	O
on	O
estrogen	B-NEG
and	O
progesterone	B-NEG
secretion	O
in	O
preovulatory	O
follicles	O
incubated	O
in	O
vitro	O
.	O

-DOCSTART-	O

The	O
mechanism	O
of	O
preventing	O
intrauterine	B-NEG
growth	I-NEG
retardation	I-NEG
with	O
Foshousan	O
plus	O
Danshen	O
by	O
protecting	O
erythrocytes	O
against	O
lipid	O
peroxidation	O
damage	O
was	O
also	O
preliminarily	O
discussed	O
.	O

-DOCSTART-	O

In	O
this	O
study	O
,	O
using	O
fibroblasts	O
derived	O
from	O
these	O
mouse	O
embryos	O
(	O
Gap-	O
-	O
P	O
.	O
van	O
der	O
Geer	O
et	O
al	O
.	O
,	O
Mol	O
.	O
Cell	O
Biol	O
.	O
,	O
17	O
1840-1847	O
,	O
1997	O
)	O
,	O
we	O
demonstrate	O
that	O
mitogen-activated	B-NEG
protein	I-NEG
kinase	I-NEG
(	O
MAPK	O
)	O
activation	O
is	O
prolonged	O
after	O
epidermal	O
growth	O
factor	O
(	O
EGF	O
)	O
,	O
but	O
not	O
lysophosphatidic	O
acid	O
,	O
stimulation	O
as	O
compared	O
with	O
wild-type	O
cells	O
.	O

-DOCSTART-	O

These	O
combined	O
data	O
suggests	O
that	O
Saibokuto	O
has	O
a	O
weak	O
immunosuppressive	B-NEG
effect	I-NEG
on	O
Df	O
induced	O
IL2	B-NEG
responsiveness	I-NEG
of	O
lymphocytes	O
from	O
asthmatic	B-NEG
children	O
.	O

-DOCSTART-	O

It	O
was	O
found	O
Chinese	O
medicine	O
Reduqing	O
(	O
RDQ	O
)	O
could	O
inhibit	O
the	O
t	O
ranscription	B-NEG
of	I-NEG
TNF	I-NEG
alpha	I-NEG
mRNA	I-NEG
induced	O
by	O
LPS	O
stimulation	O
(	O
P	O
0	O
.	O
01	O
,	O
compared	O
with	O
the	O
control	O
)	O
.	O

-DOCSTART-	O

Having	O
removed	O
a	O
pigeon	O
s	O
nest	O
,	O
a	O
20-year-old	O
woman	O
developed	O
pruritic	O
skin	B-NEG
lesions	I-NEG
due	O
to	O
infestation	O
by	O
the	O
mite	B-NEG
Dermanyssus	O
gallinae	O
(	O
De	O
Geer	O
1778	O
)	O
.	O

-DOCSTART-	O

However	O
,	O
Shosaikoto	O
itself	O
did	O
not	O
induce	O
TAT	B-NEG
activity	I-NEG
in	O
the	O
liver	O
on	O
oral	O
administration	O
or	O
in	O
cultured	O
hepatocytes	O
by	O
direct	O
addition	O
.	O

-DOCSTART-	O

Effectiveness	O
of	O
a	O
traditional	O
Chinese	O
medicine	O
,	O
Wulingsan	O
,	O
in	O
suppressing	O
the	O
development	O
of	O
nephrocalcinosis	B-NEG
induced	O
by	O
a	O
high	O
phosphorus	O
diet	O
in	O
young	O
rats	O
.	O

